Naturgy Energy Group, S.A. (GAN)
1.970
0.00 (0.00%)
Inactive · Last trade price on May 23, 2025
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Theseus Pharmaceuticals.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Theseus Pharmaceuticals.
Recommendation Trends
| Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Capital Markets | Northland Capital Markets | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +26.90% | Mar 31, 2023 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +1.52% | Nov 15, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $10 → $6.5 | Strong Buy | Maintains | $10 → $6.5 | +229.95% | Jun 28, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $26 → $10 | Strong Buy | Maintains | $26 → $10 | +407.61% | Mar 23, 2022 |
| Northland Capital Markets | Northland Capital Markets | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 23, 2022 |
Financial Forecast
Revenue This Year
138.83M
from 135.00M
Increased by 2.84%
Revenue Next Year
152.20M
from 138.83M
Increased by 9.63%
EPS This Year
-0.08
from -0.18
EPS Next Year
-0.14
from -0.08
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 144.3M | 158.2M | 170.1M |
| Avg | 138.8M | 152.2M | 163.6M |
| Low | 134.7M | 147.7M | 158.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.9% | 14.0% | 11.7% |
| Avg | 2.8% | 9.6% | 7.5% |
| Low | -0.2% | 6.4% | 4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.09 | -0.14 | -0.09 |
| Avg | -0.08 | -0.14 | -0.09 |
| Low | -0.08 | -0.13 | -0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.